Trials / Completed
CompletedNCT00057356
Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Pilot Study Evaluating the Efficacy and Safety of YM087 in Patients With Decompensated Chronic Heart Failure
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 170 (actual)
- Sponsor
- Cumberland Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, placebo-controlled, dose ranging pilot study to examine the effects of conivaptan in patients with acute decompensated heart failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | conivaptan | IV |
| DRUG | placebo | IV |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2004-03-01
- Completion
- 2004-03-01
- First posted
- 2003-04-01
- Last updated
- 2014-05-02
Locations
26 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00057356. Inclusion in this directory is not an endorsement.